John J Gormally - Net Worth and Insider Trading

John J Gormally Net Worth

The estimated net worth of John J Gormally is at least $35 dollars as of 2024-11-13. John J Gormally is the CEO of Akers Biosciences Inc and owns about 7 shares of Akers Biosciences Inc (AKER) stock worth over $35. Details can be seen in John J Gormally's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John J Gormally has not made any transactions after 2016-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John J Gormally

To

John J Gormally Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John J Gormally owns 2 companies in total, including Akers Biosciences Inc (AKER) , and TNF Pharmaceuticals Inc (TNFA) .

Click here to see the complete history of John J Gormally’s form 4 insider trades.

Insider Ownership Summary of John J Gormally

Ticker Comapny Transaction Date Type of Owner
AKER Akers Biosciences Inc 2017-10-17 director & Chief Executive Officer
TNFA TNF Pharmaceuticals Inc 2015-12-02 Chief Executive Officer

John J Gormally Latest Holdings Summary

John J Gormally currently owns a total of 1 stock. John J Gormally owns 7 shares of Akers Biosciences Inc (AKER) as of May 24, 2016, with a value of $35.

Latest Holdings of John J Gormally

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKER Akers Biosciences Inc 2016-05-24 7 4.94 35

Holding Weightings of John J Gormally


John J Gormally Form 4 Trading Tracker

According to the SEC Form 4 filings, John J Gormally has made a total of 0 transactions in Akers Biosciences Inc (AKER) over the past 5 years. The most-recent trade in Akers Biosciences Inc is the acquisition of 7 shares on May 24, 2016, which cost John J Gormally around $5,575.

Insider Trading History of John J Gormally

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John J Gormally Trading Performance

GuruFocus tracks the stock performance after each of John J Gormally's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John J Gormally is 53.13%. GuruFocus also compares John J Gormally's trading performance to market benchmark return within the same time period. The performance of stocks bought by John J Gormally within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John J Gormally's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John J Gormally

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.43 LIMIT LIMIT LIMIT LIMIT LIMIT

John J Gormally Ownership Network

Ownership Network List of John J Gormally

No Data

Ownership Network Relation of John J Gormally

Insider Network Chart

John J Gormally Owned Company Details

What does Akers Biosciences Inc do?

Who are the key executives at Akers Biosciences Inc?

John J Gormally is the director & Chief Executive Officer of Akers Biosciences Inc. Other key executives at Akers Biosciences Inc include director & Exec. Chairman and President Christopher C Schreiber , Chief Financial Officer Stuart M Benson , and 10 percent owner Hudson Bay Capital Management Lp .

Akers Biosciences Inc (AKER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akers Biosciences Inc (AKER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akers Biosciences Inc (AKER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akers Biosciences Inc (AKER)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akers Biosciences Inc Insider Transactions

No Available Data

John J Gormally Mailing Address

Above is the net worth, insider trading, and ownership report for John J Gormally. You might contact John J Gormally via mailing address: 80 Walsh Drive, Mahwah Nj 07430.